Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
129572 trials found · Page 6379 of 6479
-
New liquid form of PKU drug tested for equivalence
Knowledge-focused CompletedThis is a single center, Phase 1, randomized, open-label, single-dose, 2 treatment, 2-period,2-sequence, crossover study designed to compare the pharmacokinetics (PK) of sapropterin between the Test and Reference products in healthy Participants.
Phase 1 • Sponsor: APR Applied Pharma Research s.a. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New drug EDG-15400 tested in healthy people for first time
Knowledge-focused CompletedThe purposes of this Phase 1 study of EDG-15400 are to: 1. Learn about the safety of EDG-15400 after single and multiple doses in healthy adults 2. Learn about how EDG-15400 is tolerated after single and multiples doses in healthy adults 3. Evaluate the amount of EDG-15400 in th…
Phase 1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Teens' flat feet and weak toes may wobble balance, study finds
Knowledge-focused CompletedThe foot plays a critical role in movement and postural control, with toe flexor strength linked to gait, performance, and stability. While these relationships are well studied in adults, evidence in adolescents is limited. Pes planovalgus may reduce push-off capacity and weaken …
Sponsor: Istanbul Kültür University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Mouth care timing may impact ICU patient health
Knowledge-focused CompletedThis study aims to investigate the effect of oral care frequency on oral mucosal tissue integrity in intensive care patients.
Sponsor: Balikesir University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New drug ABBV-277 enters first human tests – no disease target yet
Knowledge-focused CompletedThe objective of this study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics (PK ) properties following a single dose of ABBV-277 in healthy adult participants.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Tiny dose, big data: healthy volunteers help map RE104's journey through the body
Knowledge-focused CompletedThe purpose of this study is to characterize the absorption, metabolism and routes of excretion of RE104 and its metabolites in healthy volunteers. This study will quantify drug and metabolites in blood, urine, and feces samples collected before study drug administration and thro…
Phase 1 • Sponsor: Reunion Neuroscience Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New psoriasis drug candidate SHR-1139 begins first human safety check
Knowledge-focused OngoingThe purpose of this study is to assess safety, PK and immunogenicity profile of a single dose of SHR-1139 in healthy volunteers
Phase 1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Healthy volunteers help unravel drug interaction mystery
Knowledge-focused CompletedThe goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with bel…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Mitopure skin patches pass safety check in 113 volunteers
Knowledge-focused CompletedThe objective of this study is to investigate the irritation and sensitization potential of 6 different topically applied test articles containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modif…
Sponsor: Amazentis SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New drug IMC-003 put to the test in healthy women – no cure expected
Knowledge-focused Recruiting nowthis study is a randomized, double-blind, placebo-controlled, single and multiple dose escalation Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of IMC-003 for injection in healthy postmenopausal women.
Phase 1 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New drug JADE101 tested in healthy people for first time
Knowledge-focused OngoingThis is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.
Phase 1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Paxlovid copycat pills put to the test – but study pulled
Knowledge-focused CancelledMedicines that may have different names or be made in different ways but have the same effect on the body are called bioequivalent. The purpose of this study is to learn about the bioequivalence of nirmatrelvir plus ritonavir after taking 2 different combination tablet forms by …
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New prosthetic control system put to the test in short study
Knowledge-focused CancelledThis study tests how well the Phantom X prosthesis control system works. The system helps control a prosthetic hand using muscle signals from the arm. You'll wear a non-invasive version for one day in the clinic. You'll practice hand movements and then do two simple tasks with bo…
Sponsor: Phantom Neuro Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
App aims to help parents of kids with diabetes, but study was withdrawn
Knowledge-focused CancelledThis study aims to identify the unmet psychoeducational needs of parents of children 8-12 years of age using insulin pump and CGM for pediatric T1D management and to leverage that information to develop an innovative app-based psychoeducational intervention to optimize use of the…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Promising combo for resistant colon cancer never gets off the ground
Disease control CancelledBackground: Metastatic colorectal cancer (mCRC) is cancer that has spread beyond the colon and rectum. Most people with mCRC die within 5 years. New immune-based treatments are making progress with some types of colon cancer. But these treatments do little for people with a type…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Parkinson's study probes blood Pressure's role in brain function
Knowledge-focused CancelledThe goal of clinical trial is to learn about how blood pressure fluctuations affect cognitive performance (thinking abilities) and brain blood flow in persons with Parkinson's disease with and without orthostatic hypotension (low blood pressure when standing). The main questions …
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Eczema cream study halted after just 3 volunteers
Symptom relief Stopped earlyThis is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermatitis condition. In participating in this study, the investigators will analyze the participants' skin microbiome, measure…
Phase 1 • Sponsor: Good Molecules, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Pfizer checks if new atirmociclib tablet matches the old one
Knowledge-focused CompletedThe purpose of this study is to understand bioequivalence (medicines that may have different names or be made in different ways, but have the same effect on the body) of the current PF-07220060 tablet formulation and the proposed higher drug load tablet that is already available …
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Withdrawn study sought to ease lymphedema fears in breast cancer patients
Knowledge-focused CancelledThis clinical trial assesses the change in lymphatic structure from placement of an intravenous (IV) line and fluid administration using a diagnostic agent, indocyanine green (ICG), with SPY (Trademark) angiography in breast cancer patients at risk for breast cancer-related lymph…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:41 UTC
-
Cancer combo trial pulled before it even started
Disease control CancelledThis is a phase Ib/II, randomized, open-label, multicenter clinical trial to evaluate the antitumor activities, safety, tolerability and pharmacokinetics (PK) of IN10018 in combination with taxane and anti-PD-1/L1 monoclonal antibody in patients with locally advanced or metastati…
Phase 1/2 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC